Skip to main content


Table 2 Quantification/interpretation of hemodynamic monitoring and changes in hemodynamic management

From: Effects of hemodynamic monitoring using a single-use transesophageal echocardiography probe in critically ill patients – study protocol for a randomized controlled trial

Quantification/interpretation of all hemodynamic monitoring Changes in hemodynamic management based on information acquired by hemodynamic monitoring?
• Systolic LV function: normal – moderately decreased – severely decreased?
• RV dysfunction: present –absent?
• Hypovolemia: present – absent?
• Clinically significant pericardial effusion: present – absent?
• Was the information acquired by hemodynamic monitoring useful to guide hemodynamic management? Yes – no?
• Is there need for further monitoring? Yes – no?
• No changes
• Additional fluids given
• Start/increase of inotropes (epinephrine, dobutamine, milrinone, aminophylline)
• Stop/decrease inotropes (epinephrine, dobutamine, milrinone, aminophylline)
• Start/increase of vasopressors (norepinephrine, vasopressin)
• Stop/decrease of vasopressors (norepinephrine, vasopressin)
• Drainage of pericardial effusion
• Other (to be specified)
  1. RV right ventricular, LV left ventricular